ENANGER – Testosterone Enanthate
- Active ingredients: Testosterone Enanthate
- Pharmacological category: Anabolic Steroid
- Composition: 250 mg/ml of Testosterone Enanthate in sesame oil
Mechanism of medicine action:
Testosterone is the primary endogenous androgen. Androgen receptors occur in many different vertebrate body system tissues, and both males and females respond similarly to similar levels. Greatly differing amounts of testosterone prenatally, at puberty, and throughout life account for a share of biological differences between males and females.
Males: Testosterone Enanthate is indicated for replacement therapy in conditions associated with a deficiency or absence of endrogenous testosterone: Primary hypogonadism testicular failure due to cryptorchidism, bilateral torsion orchitis, vanishing testis syndrome, or orchidectomy. Primary goals of therapy in these women include ablation of the ovaries. This treatment has also been used in premenopausal women with breast cancer who have benefited from ophorectomy and are considered to have a hormone responsive tumor.
Testosterone Enanthate is contradicted in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant. When administered to pregnant women, androgens cause virilization of the external genitalia of the female fetus. The degree of masculinization is related to the amount of drug given and the age of the fetus and is most likely to occur in the female fetus when the drugs are given in the first trimester. If the patient becomes pregnant while taking these drugs, she should be apprised of the potential hazard of the fetus.
Women should be observed for signs of virilization (deepening of the voice, hirsutism, acne, clitoromegaly and menstrual irregularities). A decision may be made by the patient and the physician that some virilization will be tolerated during treatment for breast carcinoma.Because androgens may alter serum cholesterol concentration, caution should be used when administering these drugs to patients with a history of myocardial infarction or coronary artery disease.
Anticoagulants, Oxyphenbutazone, Insulin, ACTH and corticosteroids. Always take it under supervision by a physician
Dosage and duration of therapy with Testosterone Enanthate Injection will depend on age, sex, diagnosis, patient’s response to treatment, and appearance of adverse effects. When properly given, injections of Testosterone Enanthate are well tolerated. Care should be taken to inject the preparation deeply into the gluteal muscle following the usual precautions for intramuscular administration. In general, total doses above 400 mg per month are not required because of the prolonged action of the preparation. Injections more frequently than every two weeks are rarely indicated.
Males: As replacement therapy, i.e., for eunuchism, the suggested dosage is 50 to 400 mg every 2 to 4 weeks.
Females: Palliation of Inoperable Mammary Cancer in Women: A dosage of 200 to 400 mg every 2 to 4 weeks is recommended. Women with metastatic breast carcinoma must be followed closely because androgen therapy occasionally appears to accelerate the disease. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit.
Store in a dark, dry place, at room temperature. Do not refrigerate. Keep out of reach of children.
Manufactured by: Thaiger Labs Thailand